Balyasny Asset Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-596,407
| Closed | -$24.4M | – | 2466 |
|
|
2024
Q2 | $24.4M | Sell |
596,407
-480,808
| -45% | -$19.7M | 0.04% | 408 |
|
|
2024
Q1 | $45.5M | Sell |
1,077,215
-864,000
| -45% | -$36.5M | 0.08% | 257 |
|
|
2023
Q4 | $82.3M | Buy |
1,941,215
+1,911,419
| +6,415% | +$81M | 0.15% | 105 |
|
|
2023
Q3 | $650K | Sell |
29,796
-80,953
| -73% | -$1.77M | ﹤0.01% | 1245 |
|
|
2023
Q2 | $3.52M | Sell |
110,749
-238,853
| -68% | -$7.59M | 0.01% | 870 |
|
|
2023
Q1 | $8.53M | Buy |
+349,602
| New | +$8.53M | 0.02% | 642 |
|